InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (2 ops.)
Discover the detailed record of transactions filed by TANNENBAUM RENEE P, Administratrice. Director active across 2 companies, notably Zogenix, INC.. In total, 6 reports have been recorded. Total volume traded: €250k. The latest transaction was disclosed on 19 March 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations6 total
013,346 shares0
Common Stock
SEC:0001415889-22-003266:0·
32,567 shares
Common Stock
SEC:0000899243-22-010303:0·
€55,0555,305 shares@ €10.377944.1% of flow
Common Stock
SEC:0001375151-21-000102·
€55,0555,305 shares@ €10.377922.1% of flow
Common Stock
SEC:0001375151-21-000102:0·
€69,7735,000 shares@ €13.954755.9% of flow
Common Stock
SEC:0001375151-21-000072·
Ideal exit: 26 Feb 2022 (T+270)
€69,7735,000 shares@ €13.954727.9% of flow
Common Stock
SEC:0001375151-21-000072:0·
Ideal exit: 26 Feb 2022 (T+270)
6 of 6 declarations
About TANNENBAUM RENEE P
Renee P. Tannenbaum is a Board Member at Zogenix, Inc. and ANI Pharmaceuticals Inc. She participates in the governance and strategy of these companies. With significant experience in the pharmaceutical sector, Renee brings valuable expertise in product development and regulation. Her commitment to innovation and improving healthcare is an asset for Zogenix and ANI.
